ARMISTICE CAPITAL, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Aridis Pharmaceuticals, Inc. Common Stock (ARDS)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Aridis Pharmaceuticals, Inc. Common Stock
Symbol: ARDS
Shares outstanding: 44.6M shares
Disclosed Ownership: 5.1M shares
Ownership: 11.4%
Form type: SCHEDULE 13G/A
Filing time: 15 May 2025, 15:22:36 UTC
Date of event: 31 Mar 2025
Previous filing: 14 Feb 2025
Next filing: 14 Aug 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	11.43%	5.1M	0	5.1M	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	11.43%	5.1M	0	5.1M	/s/ Steven Boyd	Steven Boyd